Grade @-@ neutropenia was reported in @ ( @ % ) of @ patients in the palbociclib plus letrozole group versus one ( @ % ) of @ patients in the letrozole group , leucopenia in @ ( @ % ) versus none , and fatigue in four ( @ % ) versus one ( @ % ) .